Human ebola virus species and compositions and methods thereof:
Compositions and methods including and related to the Ebola Bundibugyo virus (EboBun) are provided.
Compositions are provided that are operable as immunogens to elicit and immune response or protection from EboBun challenge in a subject such as a primate. Inventive methods are directed to detection and treatment of EboBun infection.
For more information:
➖❌❌➖ Harvesting Ebola from victims to file patents:
From the patent description on the EboBun virus, we know that the U.S. government:
1) Extracts Ebola viruses from patients.
2) Claims to have “invented” that virus.
3) Files for monopoly patent protection on the virus.
To understand why this is happening, you have to first understand what a patent really is and why it exists. A patent is a government-enforced monopoly that is exclusively granted to persons or organizations. It allows that person or organization to exclusively profit from the “invention” or deny others the ability to exploit the invention for their own profit.
According to Oxford Dictionaries:
“A government authority or licence conferring a right or title for a set period, especially the sole right to exclude others from making, using, or selling an invention.”
It brings up the obvious question here: Why would the U.S. government claim to have “invented” Ebola and then claim an exclusively monopoly over its ownership?
➖❌❌➖ U.S. Government claims exclusive ownership over its “invention” of Ebola:
The “SUMMARY OF THE INVENTION” section of the patent document also clearly claims that the U.S. government is claiming “ownership” over all Ebola viruses that share as little as 70% similarity with the Ebola it “invented”:
…invention relates to the isolated EboBun virus that morphologically and phylogenetically relates to known members filoviridae… In another aspect, the invention provides an isolated hEbola EboBun virus comprising a nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of: a) a nucleotide sequence set forth in SEQ ID NO: 1; b) a nucleotide sequence that hybridizes to the sequence set forth in SEQ ID NO: 1 under stringent conditions; and c) a nucleotide sequence that has at least 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% identity to the SEQ ID NO:
1. In another aspect, the invention provides the complete genomic sequence of the hEbola virus EboBun.
For more information:
📍Why Does The CDC Own A Patent n Ebola ‘Invention’?:
📍Coincidence? “Ebola Vaccine” Goes Hot In The News Just Days Before “Ebola Scare” In Alabama: